Morphogenics as a Tool for Target Discovery and Drug Development

Keywords

Humanities, Philosophy

References

• Genomic organization of the human PMS2 gene family.Nicholas C. Nicolaides, Kenneth C. Carter, Brenda K. Shell — 1995
• Reduction of Stability of Arabidopsis Genomic and Transgenic DNA-Repeat Sequences (Microsatellites) by Inactivation of AtMSH2 Mismatch-Repair Function1Jeffrey M. Leonard, Stephanie R. Bollmann, John B. Hays — 2003
• Mismatch repair, genetic stability, and cancer.Paul Modrich — 1994
• Rapid generation of plant traits via regulation of DNA mismatch repair.Qimin Chao, Christine D. Sullivan, John M. Getz — 2005
• Microsatellite instability in Drosophila spellchecker1 (MutS homolog) mutants.Carlos C. Flores, William R. Engels — 1999
• Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repairMicheline K. Strand, Tomas A. Prolla, R. Michael Liskay — 1993
• Mismatch repair deficiency in phenotypically normal human cellsRamon Parsons, Guo‐Min Li, Matthew J. Longley — 1995
• DNA binding by yeast Mlh1 and Pms1: implications for DNA mismatch repair.Mark C. Hall — 2003
• Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrationsB. Michael Ghadimi, Dan L. Sackett, Michael J. Difilippantonio — 2000
• The effect of folate deficiency on the hprt mutational spectrum in Chinese hamster ovary cells treated with monofunctional alkylating agents.Richard F. Branda, Amy Lafayette, John P. O’Neill — 1999
• Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma.Kathy Q. Cai — 2004
• Selection of Hybrids from Matings of Fibroblasts in vitro and Their Presumed RecombinantsJohn W. Littlefield — 1964
• Contribution of the Mismatch DNA Repair System to the Generation of Stationary-Phase-Induced Mutants of Bacillus subtilisMario Pedraza‐Reyes, Ronald E. Yasbin — 2004
• Replication errors: cha(lle)nging the genomeJ. Jiricny — 1998
• Evaluation of EMS-induced DNA damage in the single cell gel electrophoresis (Comet) assay and with flow cytometric analysis of micronuclei.Elizabeth D. Wagner, Diana Anderson, Alok Dhawan — 2003
• A Naturally Occurring hPMS2 Mutation Can Confer a Dominant Negative Mutator PhenotypeNicholas C. Nicolaides, Susan J. Littman, Paul Modrich — 1998
• Gene Expression Analysis of Tumor Spheroids Reveals a Role for Suppressed DNA Mismatch Repair in Multicellular Resistance to Alkylating AgentsGiulio Francia, Shan Man, Beverly A. Teicher — 2004
• Characterization of sporadic colon cancer by patterns of genomic instability.Ajay Goel, Christian Arnold, Donna Niedzwiecki — 2003
• The Concept of LawHerbert Lionel Adolphus Hart — 1961

Cited by

• Antibody expression and productionMohamed Al‐Rubeai — 2011
• A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancerZhehai Wang, Huan Shi, Jun Guo — 2015
• Folate receptor α: A storied past and promising future in immunotherapyGuy T. Clifton, Alan K. Sears, Kevin S. Clive — 2011
• Vintafolide: a novel targeted agent for epithelial ovarian cancer.Whitney A. Spannuth Graybill, Robert L. Coleman — 2014
• Farletuzumab in epithelial ovarian carcinomaWhitney A. Spannuth, Anil K. Sood, Robert L. Coleman — 2010
• Protein and Genome Evolution in Mammalian Cells for Biotechnology ApplicationsBrian S. Majors, Gisela G. Chiang, Michael J. Betenbaugh — 2009
• Farletuzumab in Lung CancerAnish Thomas, Julia D. Maltzman, Raffit Hassan — 2013
• Role of Farletuzumab in Epithelial Ovarian CarcinomaDanijela Jelovac, Deborah K. Armstrong — 2012
• Developing novel biopharmaceutical products through morphogenicsNicholas C. Nicolaides, Phillip M Sass, Qimin Chao — 2007
• Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha.Wolfgang Ebel, Eric Routhier, Brian Foley — 2007
• Monoclonal antibodies: a morphing landscape for therapeuticsNicholas C. Nicolaides, Philip M. Sass, Luigi Grasso — 2006
• Farletuzumab for NSCLC: exploiting a well-known metabolic pathway for a new therapeutic strategyGiuseppe Bronte, Francesca Lo Vullo, Gianfranco Pernice — 2015
• Farletuzumab in the treatment of ovarian cancerGerard Walls, Martin Gore — 2016
• Engineering Antibodies for Cancer TherapyLisa E. Goldsmith, M. Robinson — 2011
• Expression Systems for Recombinant Biopharmaceutical Production by Mammalian Cells in CultureAdam J. Brown, D. Kalsi, Alejandro Fernandez‐Martell — 2017
• Integrative Systems Biology II—Molecular Biology: Phase 2 Lead Discovery and In Silico ScreeningA. Prokop, S. Michelson — 2012
• Improving Protein and Antibody Yields in Scalable Mammalian-Cell–Based ManufacturingQimin Chao, Yuhong Zhou, E. Routhier — 2006
• A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancerHuan Shi, Jun Guo, Changzheng Li — 2015
• Anti-FR Antibody Generation and Engineering: Development of New Therapeutic ToolsS. Canevari, M. Figini — 2011
• This information is current as Apoptosis in Spermatogenesis Expression of Aire and the Early Wave of Anderson andC. Schaller, C. J. Wang, G. Beck-Engeser — 2008

Related papers

No related papers recorded.